FDA is requesting immediate removal of all Rx and over-the-counter ranitidine (Zantac) from the U.S. market. https://go.usa.gov/xvC7t 

An impurity known as NDMA in some ranitidine products increases over time and when stored at higher than room temperatures, may result in consumer exposure to unacceptable levels of this impurity.